CYTOTOXICITY MEDIATED BY T-CELLS AND NATURAL-KILLER-CELLS IS GREATLY IMPAIRED IN PERFORIN DEFICIENT MICE

被引:1532
作者
KAGI, D
LEDERMANN, B
BURKI, K
SEILER, P
ODERMATT, B
OLSEN, KJ
PODACK, ER
ZINKERNAGEL, RM
HENGARTNER, H
机构
[1] SANDOZ PHARMA LTD, PRECLIN RES, CH-4002 BASEL, SWITZERLAND
[2] UNIV MIAMI, DEPT MICROBIOL & IMMUNOL, MIAMI, FL 33101 USA
关键词
D O I
10.1038/369031a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Perforin-deficient mice have been generated by homologous recombination to determine whether the effects of CD8(+) cytolytic T cells and natural killer cells are mediated by pore formation involving perforin. These mice are viable and fertile and have normal numbers of CD8(+) T cells and natural killer cells which do not lyse virus-infected or allogeneic fibroblasts or natural killer target cells in vitro. The mice fail to clear lymphocytic choriomeningitis virus and they eliminate fibrosarcoma tumour cells with reduced efficiency. Perforin is therefore a key effector molecule for T-cell- and natural killer-cell-mediated cytolysis.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 49 条
[1]   INHIBITION OF LYMPHOCYTE MEDIATED CYTOTOXICITY BY PERFORIN ANTISENSE OLIGONUCLEOTIDES [J].
ACHAORBEA, H ;
SCARPELLINO, L ;
HERTIG, S ;
DUPUIS, M ;
TSCHOPP, J .
EMBO JOURNAL, 1990, 9 (12) :3815-3819
[2]   DISTINCT PATTERNS OF VIRUS-SPECIFIC T-CELL-MEDIATED CYTOLYSIS OF TRANSFORMED VERSUS PRIMARY TARGET-CELLS [J].
BAENZIGER, J ;
HENGARTNER, H ;
ZINKERNAGEL, RM ;
GROSCURTH, P .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (04) :411-423
[3]   QUANTIFICATION OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS WITH AN IMMUNOLOGICAL FOCUS ASSAY IN 24-WELL OR 96-WELL PLATES [J].
BATTEGAY, M ;
COOPER, S ;
ALTHAGE, A ;
BANZIGER, J ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
JOURNAL OF VIROLOGICAL METHODS, 1991, 33 (1-2) :191-198
[4]  
BERKE G, 1987, TRANSPLANT P, V19, P412
[5]  
BINDER D, 1991, J IMMUNOL, V146, P4301
[6]  
Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2
[7]  
Cerottini J C, 1974, Adv Immunol, V18, P67, DOI 10.1016/S0065-2776(08)60308-9
[8]   THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO [J].
COBBOLD, SP ;
JAYASURIYA, A ;
NASH, A ;
PROSPERO, TD ;
WALDMANN, H .
NATURE, 1984, 312 (5994) :548-551
[9]   CYTOLYSIS BY H-2-SPECIFIC-T KILLER CELLS - ASSEMBLY OF TUBULAR COMPLEXES ON TARGET MEMBRANES [J].
DENNERT, G ;
PODACK, ER .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (05) :1483-1495
[10]  
DOURMASHKIN RR, 1980, CLIN EXP IMMUNOL, V42, P554